These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 21169414)

  • 1. Activation of NF-{kappa}B by TMPRSS2/ERG Fusion Isoforms through Toll-Like Receptor-4.
    Wang J; Cai Y; Shao LJ; Siddiqui J; Palanisamy N; Li R; Ren C; Ayala G; Ittmann M
    Cancer Res; 2011 Feb; 71(4):1325-33. PubMed ID: 21169414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the TMPRSS2-ERG gene fusion in prostate cancer.
    Tomlins SA; Laxman B; Varambally S; Cao X; Yu J; Helgeson BE; Cao Q; Prensner JR; Rubin MA; Shah RB; Mehra R; Chinnaiyan AM
    Neoplasia; 2008 Feb; 10(2):177-88. PubMed ID: 18283340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pleiotropic biological activities of alternatively spliced TMPRSS2/ERG fusion gene transcripts.
    Wang J; Cai Y; Yu W; Ren C; Spencer DM; Ittmann M
    Cancer Res; 2008 Oct; 68(20):8516-24. PubMed ID: 18922926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Celastrol suppresses tumor cell growth through targeting an AR-ERG-NF-κB pathway in TMPRSS2/ERG fusion gene expressing prostate cancer.
    Shao L; Zhou Z; Cai Y; Castro P; Dakhov O; Shi P; Bai Y; Ji H; Shen W; Wang J
    PLoS One; 2013; 8(3):e58391. PubMed ID: 23554889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of the NKX3.1 tumorsuppressor promotes the TMPRSS2-ERG fusion gene expression in prostate cancer.
    Thangapazham R; Saenz F; Katta S; Mohamed AA; Tan SH; Petrovics G; Srivastava S; Dobi A
    BMC Cancer; 2014 Jan; 14():16. PubMed ID: 24418414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of TMPRSS2-ERG fusion high-grade prostatic intraepithelial neoplasia and potential clinical implications.
    Mosquera JM; Perner S; Genega EM; Sanda M; Hofer MD; Mertz KD; Paris PL; Simko J; Bismar TA; Ayala G; Shah RB; Loda M; Rubin MA
    Clin Cancer Res; 2008 Jun; 14(11):3380-5. PubMed ID: 18519767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Function of phosphorylation of NF-kB p65 ser536 in prostate cancer oncogenesis.
    Zhang L; Shao L; Creighton CJ; Zhang Y; Xin L; Ittmann M; Wang J
    Oncotarget; 2015 Mar; 6(8):6281-94. PubMed ID: 25749044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highly specific targeting of the TMPRSS2/ERG fusion gene using liposomal nanovectors.
    Shao L; Tekedereli I; Wang J; Yuca E; Tsang S; Sood A; Lopez-Berestein G; Ozpolat B; Ittmann M
    Clin Cancer Res; 2012 Dec; 18(24):6648-57. PubMed ID: 23052253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of FOXO1 Cooperates with TMPRSS2-ERG Overexpression to Promote Prostate Tumorigenesis and Cell Invasion.
    Yang Y; Blee AM; Wang D; An J; Pan Y; Yan Y; Ma T; He Y; Dugdale J; Hou X; Zhang J; Weroha SJ; Zhu WG; Wang YA; DePinho RA; Xu W; Huang H
    Cancer Res; 2017 Dec; 77(23):6524-6537. PubMed ID: 28986382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toll-Like Receptor 4 (TLR4)/Cyclooxygenase-2 (COX-2) Regulates Prostate Cancer Cell Proliferation, Migration, and Invasion by NF-κB Activation.
    Wang W; Wang J
    Med Sci Monit; 2018 Aug; 24():5588-5597. PubMed ID: 30098292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ERG oncoprotein expression in prostate cancer: clonal progression of ERG-positive tumor cells and potential for ERG-based stratification.
    Furusato B; Tan SH; Young D; Dobi A; Sun C; Mohamed AA; Thangapazham R; Chen Y; McMaster G; Sreenath T; Petrovics G; McLeod DG; Srivastava S; Sesterhenn IA
    Prostate Cancer Prostatic Dis; 2010 Sep; 13(3):228-37. PubMed ID: 20585344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of variant TMPRSS2/ERG fusion messenger RNAs is associated with aggressive prostate cancer.
    Wang J; Cai Y; Ren C; Ittmann M
    Cancer Res; 2006 Sep; 66(17):8347-51. PubMed ID: 16951141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cooperativity of TMPRSS2-ERG with PI3-kinase pathway activation in prostate oncogenesis.
    King JC; Xu J; Wongvipat J; Hieronymus H; Carver BS; Leung DH; Taylor BS; Sander C; Cardiff RD; Couto SS; Gerald WL; Sawyers CL
    Nat Genet; 2009 May; 41(5):524-6. PubMed ID: 19396167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody-based detection of ERG rearrangement-positive prostate cancer.
    Park K; Tomlins SA; Mudaliar KM; Chiu YL; Esgueva R; Mehra R; Suleman K; Varambally S; Brenner JC; MacDonald T; Srivastava A; Tewari AK; Sathyanarayana U; Nagy D; Pestano G; Kunju LP; Demichelis F; Chinnaiyan AM; Rubin MA
    Neoplasia; 2010 Jul; 12(7):590-8. PubMed ID: 20651988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TMPRSS2-ERG fusion protein regulates insulin-like growth factor-1 receptor (IGF1R) gene expression in prostate cancer: involvement of transcription factor Sp1.
    Meisel Sharon S; Pozniak Y; Geiger T; Werner H
    Oncotarget; 2016 Aug; 7(32):51375-51392. PubMed ID: 27285981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Palmitate induces interleukin-8 expression in human aortic vascular smooth muscle cells via Toll-like receptor 4/nuclear factor-κB pathway (TLR4/NF-κB-8).
    Quan J; Liu J; Gao X; Liu J; Yang H; Chen W; Li W; Li Y; Yang W; Wang B
    J Diabetes; 2014 Jan; 6(1):33-41. PubMed ID: 23826669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of steroid and peptide hormone receptors, metabolic enzymes and EMT-related genes in prostate tumors in relation to the presence of the TMPRSS2/ERG fusion.
    Gerashchenko GV; Mevs LV; Chashchina LI; Pikul MV; Gryzodub OP; Stakhovsky EO; Kashuba VI
    Exp Oncol; 2018 Jun; 40(2):101-108. PubMed ID: 29949537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ETV4 promotes late development of prostatic intraepithelial neoplasia and cell proliferation through direct and p53-mediated downregulation of p21.
    Cosi I; Pellecchia A; De Lorenzo E; Torre E; Sica M; Nesi G; Notaro R; De Angioletti M
    J Hematol Oncol; 2020 Aug; 13(1):112. PubMed ID: 32791988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of the TMPRSS2:ERG gene fusion in prostate cancer.
    Wang Z; Wang Y; Zhang J; Hu Q; Zhi F; Zhang S; Mao D; Zhang Y; Liang H
    Mol Med Rep; 2017 Oct; 16(4):5450-5458. PubMed ID: 28849022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TMPRSS2-ERG Fusion Promotes Recruitment of Regulatory T cells and Tumor Growth in Prostate Cancer.
    Shan L; Ji T; Su X; Shao Q; Du T; Zhang S
    Am J Med Sci; 2018 Jul; 356(1):72-78. PubMed ID: 30049331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.